
KHP Ventures
AI Verified
United Kingdom
Venture Capital
Education Centre, 75-79, York Road, South Bank, Waterloo, London Borough of Lambeth, London, Greater London, England, SE1 7NJ, United Kingdom
2021
Criteria | Requirements | Match |
---|---|---|
Regions | Northern Europe, Western Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Seed, Series A, Series B, Pre-Seed |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
KHP Ventures stands as the pioneering venture capital fund established and supported by the National Health Service (NHS), focusing exclusively on digital health and medical technology innovations. Created through a collaborative effort between King's Health Partners and Guy's & St Thomas' NHS Foundation Trust, the fund leverages deep healthcare expertise to identify and nurture transformative solutions addressing critical healthcare challenges. Their unique position within the NHS ecosystem provides unparalleled access to clinical settings, patient populations, and healthcare professionals—creating a distinctive advantage in evaluating potential investments.
The fund primarily targets early-stage companies developing breakthrough technologies across telehealth, AI-driven diagnostics, remote monitoring solutions, and novel medical devices. With investment tickets typically ranging from £250,000 to £3 million, KHP Ventures supports promising startups from seed through Series A funding rounds. Their portfolio includes notable companies such as digital therapeutic developers, precision medicine platforms, and healthcare data analytics innovators that demonstrate potential for significant clinical impact and commercial viability.
Beyond capital investment, KHP Ventures offers portfolio companies invaluable strategic advantages including accelerated clinical validation pathways, regulatory navigation support, and access to the NHS procurement framework. This comprehensive approach significantly reduces time-to-market for healthcare innovations while ensuring solutions are developed with real-world clinical requirements in mind. The fund's leadership team combines seasoned investment professionals with experienced clinicians and healthcare administrators, creating a multidisciplinary expertise base that thoroughly evaluates both clinical efficacy and commercial potential.
While maintaining strong roots in the UK healthcare system, KHP Ventures increasingly supports companies with international expansion potential, recognizing that healthcare challenges transcend borders. Their investment thesis prioritizes solutions that demonstrate scalability across different healthcare systems and markets. The fund actively collaborates with international healthcare providers, technology partners, and complementary investors to create global pathways for healthcare innovation. By bridging the gap between clinical needs and technological capabilities, KHP Ventures is instrumental in accelerating the adoption of digital solutions that enhance patient outcomes, improve operational efficiency, and address the evolving demands of modern healthcare delivery.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
KHP Ventures maintains its global headquarters in United Kingdom, serving as the strategic center for its operations. The company's primary corporate offices are located at Education Centre, 75-79, York Road, South Bank, Waterloo, London Borough of Lambeth, London, Greater London, England, SE1 7NJ, United Kingdom.
KHP Ventures focuses its investment activities on companies operating in the following stages: Seed, Series A, Series B, Pre-Seed. KHP Ventures provides strategic capital and expertise to support promising businesses at these critical phases of development.
KHP Ventures maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Northern Europe, Western Europe.
KHP Ventures was established in 2021, marking the beginning of its journey as an investment firm.
KHP Ventures is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.